Prostatic Size Reduction Following of Leuprorelin Acetate
NCT06184464 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2024-09-19
Summary
To determine the possible reduction in prostate size following the administration of Leuprelin prior to the application of radiotherapy.
Conditions
- Prostate Cancer Adenocarcinoma
- Prostate Adenocarcinoma
Interventions
- OTHER
-
ACETATE LEUPRELINE
USE ACETATE LEUPRELINE BEFORE AND AFTER PROSTATE DELIMITATION
Sponsors & Collaborators
-
Consorci Sanitari de Terrassa
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 95 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-02
- Primary Completion
- 2024-12-15
- Completion
- 2024-12-15
Countries
- Spain
Study Locations
More Related Trials
-
Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma
NCT01011751 ·Status: COMPLETED ·Phase: PHASE3
-
Open Randomized Clinical Trial to Evaluate the Effects of Intermittent Caloric Restriction in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
NCT03669692 ·Status: WITHDRAWN ·Phase: NA
-
Registry: TPLA for LUTS
NCT03776006 ·Status: NOT_YET_RECRUITING
-
A Randomized Triple-Blind Placebo-Controlled Study to Evaluate the Effects of a Supplement on Lower Urinary Tract Symptoms in Men.
NCT06504472 ·Status: COMPLETED ·Phase: NA
-
Economic Evaluation of Prostatic Urethral Lift
NCT04726748 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Outcomes of Laser Prostatectomy
NCT03318991 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the ProstaPlant Prostate Stent Insertion in Ex Vivo Human Prostate
NCT00468026 ·Status: UNKNOWN ·Phase: PHASE1
-
Focal Laser Ablation for Benign Prostatic Hyperplasia
NCT04044573 ·Status: UNKNOWN ·Phase: NA
-
Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy
NCT00201630 ·Status: UNKNOWN ·Phase: PHASE3
-
Prostate Single Port & Laser Enucleation Comparison Trial
NCT06224218 ·Status: RECRUITING ·Phase: NA
-
Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)
NCT01078545 ·Status: COMPLETED
-
Effectiveness of Smartconsent in Improving Understanding of Informed Consent
NCT04856943 ·Status: COMPLETED ·Phase: NA
-
Prostatic Urethral Lift in Subject With Acute Urinary Retention
NCT03194737 ·Status: COMPLETED ·Phase: NA
-
IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation
NCT06157164 ·Status: TERMINATED
-
Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy
NCT05244486 ·Status: RECRUITING ·Phase: NA
-
Botulinum Toxin Injection With Prostate Brachytherapy
NCT00681148 ·Status: WITHDRAWN ·Phase: PHASE2
-
Comparing UroLift Experience Against Rezūm
NCT04338776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sexual Dysfunction and Adaptation in Couples Affected by Prostate Cancer Surgery
NCT00335634 ·Status: COMPLETED
-
Prostatic Hyperplasia Treatment and Cancer Prevention
NCT03064282 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia
NCT05236634 ·Status: UNKNOWN ·Phase: NA
-
Protocollo N 2014 - Benign Prostatic Hyperplasia
NCT06182189 ·Status: RECRUITING
-
Results of Selective Prostatic Arterial Embolization in Patients With Indwelling Urinary Catheter Due to Benign Prostatic Hyperplasia Refractory to Medical Treatment.
NCT01931605 ·Status: TERMINATED ·Phase: PHASE3
-
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
NCT01876706 ·Status: COMPLETED ·Phase: NA
-
Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer
NCT01081873 ·Status: COMPLETED
-
A Study of Tadalafil After Radical Prostatectomy
NCT01026818 ·Status: COMPLETED ·Phase: PHASE4